First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 6, Pages 1488
Publisher
MDPI AG
Online
2020-06-09
DOI
10.3390/cancers12061488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches
- (2019) Mirjam Gerwing et al. Nature Reviews Clinical Oncology
- R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
- (2019) Andrés J. M. Ferreri et al. BLOOD
- Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis
- (2019) Araci Rondon et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Myeloid cell–synthesized coagulation factor X dampens antitumor immunity
- (2019) Claudine Graf et al. Science Immunology
- Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non‐Small Cell Lung Cancer Patients
- (2018) Matteo Sarocchi et al. ONCOLOGIST
- Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
- (2018) Torsten Kessler et al. Translational Oncology
- Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial
- (2017) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer
- (2017) Lars Henning Schmidt et al. LUNG CANCER
- Potential therapeutic impact of CD13 expression in non-small cell lung cancer
- (2017) Lars Henning Schmidt et al. PLoS One
- Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome
- (2016) Kai M. Eggers et al. CLINICAL CHEMISTRY
- Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
- (2016) Janine Stucke-Ring et al. Oncotarget
- In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer 68Ga-NOTA-c(NGR)
- (2015) Gábor Máté et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Synthesis and evaluation of novel Tc-99 m labeled NGR-containing hexapeptides as tumor imaging agents
- (2015) Dae-Weung Kim et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR
- (2015) Caroline Brand et al. MOLECULAR PHARMACEUTICS
- Radiolabeled NGR phage display peptide sequence for tumor targeting
- (2014) B.L. Faintuch et al. APPLIED RADIATION AND ISOTOPES
- Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines
- (2014) WENQING LIANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroPET Imaging of CD13 Expression Using a 64Cu-Labeled Dimeric NGR Peptide Based on Sarcophagine Cage
- (2014) Guoquan Li et al. MOLECULAR PHARMACEUTICS
- Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF–NGR using multi-modal imaging
- (2013) Thorsten Persigehl et al. ANGIOGENESIS
- Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
- (2013) Angelo Corti et al. BIODRUGS
- Anticancer Therapy by Tumor Vessel Infarction with Polyethylene Glycol Conjugated Retargeted Tissue Factor
- (2013) Christian Schwöppe et al. JOURNAL OF MEDICINAL CHEMISTRY
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
- (2013) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac troponin level elevations not related to acute coronary syndromes
- (2013) Evangelos Giannitsis et al. Nature Reviews Cardiology
- Non-invasive imaging for studying anti-angiogenic therapy effects
- (2013) Josef Ehling et al. THROMBOSIS AND HAEMOSTASIS
- Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment
- (2012) L. Guzman-Rojas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- How to Interpret Elevated Cardiac Troponin Levels
- (2011) Vinay S. Mahajan et al. CIRCULATION
- The 10 commandments of troponin, with special reference to high sensitivity assays
- (2011) A. S. Jaffe HEART
- Aminopeptidase N (CD13) as a target for cancer chemotherapy
- (2010) Malin Wickström et al. CANCER SCIENCE
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- Tissue-factor fusion proteins induce occlusion of tumor vessels
- (2010) Christian Schwöppe et al. THROMBOSIS RESEARCH
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- Assessing Risk of Venous Thromboembolism in the Patient With Cancer
- (2009) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now